2[2]Suzuki A, Miyagawa-Tomita S. Nakazawa M, et al. Remodeling of coronary artery lesions due to Kawasaki disease: Comparison of arteriographic and immunohistochemical findings. Jpn Heart J, 2000, 41: 245- 256.
3[3]Rowley A, Shulman S. Kawasaki disease. In: Behrman RE, Kliegman RM, Arvin AM, eds. Nelson textbook of pediatrics. Philadeiphia: Saunders, 2000: 725 - 727.
4[9]0nouchi Z, Kawasaki T.Overview of pharmacological treatment of Kawasaki disease. Drugs, 1999, 58: 813-822.
6Dajani AS, Taubert KA, Gerber MA, et al. Diagnosis and therapy of Kawasaki disease in children [J]. Circulation, 1993, 87(5): 1766-1780.
7Newburger JW. Kawasaki disease: Who is at risk [J]? J Pediatrics, 2000, 137(2): 149-152.
8McCrindlie BW, Shulman ST, Burns JC, et al. Summary and abstracts of the Sixth International Kawasaki Disease Symposium [J]. Pediatr Res, 2000, 47: 544-570.
9Yanagawa H, Nakamura Y, Yashiro M,et al. A nationwide incidence survey of Kawasake disease in 1985-1986 in Japan [J]. J Infect Disease, 1988, 158(6): 1296-1301.
10Meissner HC, Schlivert PM, Leung DY, et al, Mechanisms of immunoglobulin action: observations on Kawasaki syndrome and RSV prophylaxis [J]. Immunol Rev, 1994, 139: 109-123.
